Director, Multiomics Bioinformatics
Illumina
Summary
The Director, Bioinformatics will provide strategic leadership for Illumina's multiomics bioinformatics portfolio, spanning single cell, spatial biology, proteomics, epigenomics, and emerging multiomics technologies. Leading a team of bioinformatics scientists and engineers, this leader will define and execute informatics strategies that enable end-to-end customer multiomics workflows. The role will involve partnering closely with Product Management, Assay Development, Software Engineering, Clinical Development, and Commercial organizations to align bioinformatics capabilities with product roadmaps, customer needs, and business objectives.
Job description
Responsibilities
- Strategy -- define and drive bioinformatics strategy across Illumina's multiomics portfolio, including single cell, spatial biology, proteomics, epigenomics, and emerging multiomics technologies
- Vision -- establish the long-term vision for customer-facing informatics experiences and end-to-end product workflows
- Innovation -- drive innovation in analysis methods, AI-enabled workflows, and next-generation multiomics capabilities
- Leadership -- lead, develop, and grow a team of bioinformatics scientists and engineers, and lead programs from concept through commercial launch
- Partnership -- represent Bioinformatics and partner cross-functionally to develop technology roadmaps and investment priorities
Requirements
- PhD in Bioinformatics, Computational Biology, Computer Science, Statistics, Genomics, or related scientific discipline, with 10+ years of relevant experience preferred
- Demonstrated leadership experience managing complex bioinformatics organizations and programs
- Track record of delivering customer-facing software, analytical methods, or informatics products, including support of commercial launches
- Experience leading cross-functional product development initiatives
- Strong understanding of NGS, genomics, transcriptomics, proteomics, or related multiomics technologies
- Experience with cloud-scale informatics platforms, AI/ML technologies, and large-scale biological data analysis
- Excellent communication and stakeholder management skills
Experience/Education
- Typically requires a Bachelor's degree and a minimum of 18 years of related experience, with 10+ years of Management experience.
Requirements
- PhD in Bioinformatics, Computational Biology, Computer Science, Statistics, Genomics, or related scientific discipline
- 10+ years of relevant experience preferred
- Demonstrated leadership experience managing complex bioinformatics organizations and programs
- Track record of delivering customer-facing software, analytical methods, or informatics products, including support of commercial launches
- Experience leading cross-functional product development initiatives
- Strong understanding of NGS, genomics, transcriptomics, proteomics, or related multiomics technologies
- Experience with cloud-scale informatics platforms, AI/ML technologies, and large-scale biological data analysis
- Excellent communication and stakeholder management skills
- Typically requires a Bachelor's degree and a minimum of 18 years of related experience, with 10+ years of Management experience
Benefits
- Health insurance
- Dental insurance
- Vision insurance
- Retirement benefits
- Paid time off
- Family planning
- Genomics sequencing access
- Variable cash programs
- Equity
Company overview
Illumina is a global leader in genomics technology, founded in 1998 and headquartered in San Diego, California. As a pioneering biotechnology company, Illumina specializes in developing, manufacturing, and marketing integrated systems for genetic analysis, with a primary focus on DNA sequencing and array-based technologies. The company's mission is to improve human health by unlocking the power of the genome, serving customers across research, clinical, and applied markets worldwide. Illumina's innovative platforms, including the NovaSeq, HiSeq, MiSeq, and NextSeq series, have revolutionized genomic research and clinical applications, enabling breakthroughs in personalized medicine, disease research, and drug development. With over 9,000 employees across 27 countries, Illumina has established itself as the dominant force in next-generation sequencing, processing more than 90% of all DNA sequencing data globally. The company's technologies support diverse applications from cancer research and rare disease diagnosis to agricultural genomics and infectious disease surveillance, making genomic insights accessible to researchers and clinicians worldwide.